Search Results 401-410 of 17648 for Glucocorticoids

  1. Mayo Clinic

    YouTube - Mayo Clinic Led Study on Long QT Syndrome Sheds Light on Genetic Testing · Share · Tweet.

  2. Elotuzumab In Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

    Presence of a condition other than IgG4-RD that (e.g., asthma) is likely to require systemic Glucocorticoids (GC) for disease control during the period of the ...

  3. Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways - Mayo Clinic

    Chronic oral glucocorticoid use, use of oral or injected steroids within the past three weeks, use of high-dose inhaled steroids (> 1000mcg/day) within the ...

  4. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Calcium and calcium supplements: Achieving the right balance - Mayo Clinic

    An overview of glucocorticoid-induced osteoporosis. In: Endotext. https://www.ncbi.nlm.nih.gov/books/NBK278968/. Accessed Aug. 26, 2025. Liu L, et al. The ...

  6. A Study To Assess The Safety And Tolerability Of CFT7455 In Relapsed/Refractory Non-Hodgkin's Lymphoma Or Multiple Myeloma - Mayo Clinic

    - Received at least 3 prior treatment regimens including lenalidomide, pomalidomide, a proteasome inhibitor, a glucocorticoid and an anti-CD38 antibody.

  7. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  8. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy - Mayo Clinic

    About this study. The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic ...

  9. Publications - Travis J. McKenzie, M.D. - Mayo Clinic

    Diabetes Remission After Bariatric Surgery in Patients on Glucocorticoids: A Pilot Study. Surg Laparosc Endosc Percutan Tech. 2021 Dec 15; 32 (2):236-240

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...